From: A pan-cancer somatic mutation embedding using autoencoders
Primary site | Project name | Test samples | AUC latent | AUC De. | AUC Nd. |
---|---|---|---|---|---|
Head and neck | ORCA-IN | 36 | 0.75 | 0.50 | 0.55 |
Brain | LGG-US | 56 | 0.81 | 0.62 | 0.80 |
Blood | CLLE-ES | 102 | 0.83 | 0.84 | 0.76 |
Head and neck | THCA-SA | 28 | 0.82 | 0.66 | 0.81 |
Liver | LINC-JP | 79 | 0.54 | 0.50 | 0.50 |
Lung | LUSC-KR | 34 | 0.77 | 0.57 | 0.50 |
Skin | GACA-CN | 24 | 0.79 | 0.50 | 0.50 |
Stomach | LICA-FR | 49 | 0.67 | 0.50 | 0.51 |
Blood | ESCA-CN | 65 | 0.77 | 0.5 | 0.61 |
Lung | EOPC-DE | 40 | 0.81 | 0.74 | 0.55 |
Colorectal | COCA-CN | 63 | 0.60 | 0.50 | 0.51 |
Skin | SKCM-US | 67 | 0.84 | 0.50 | 0.50 |
Liver | LICA-CN | 79 | 0.61 | 0.50 | 0.50 |
Blood | ALL-US | 15 | 0.83 | 0.91 | 0.94 |
Skin | SKCA-BR | 20 | 0.84 | 0.50 | 0.50 |
Brain | GBM-US | 55 | 0.87 | 0.50 | 0.66 |
Nervous system | NBL-US | 18 | 0.96 | 0.95 | 0.96 |
Blood | LAML-KR | 41 | 0.97 | 0.73 | 0.64 |
Prostate | PRAD-UK | 28 | 0.65 | 0.5 | 0.50 |
Prostate | PRAD-US | 51 | 0.83 | 0.58 | 0.74 |
Blood | MALY-DE | 49 | 0.82 | 0.50 | 0.50 |
Kidney | KIRC-US | 82 | 0.90 | 0.50 | 0.58 |
Brain | PBCA-DE | 90 | 0.79 | 0.77 | 0.59 |
Kidney | RECA-EU | 49 | 0.84 | 0.5 | 0.5 |
Blood | AML-US | 18 | 0.94 | 0.96 | 0.96 |
Breast | BRCA-UK | 28 | 0.59 | 0.50 | 0.50 |
Kidney | KIRP-US | 33 | 0.90 | 0.50 | 0.57 |
Prostate | PRAD-CA | 58 | 0.88 | 0.71 | 0.50 |
Stomach | STAD-US | 58 | 0.84 | 0.50 | 0.50 |
Stomach | GACA-JP | 115 | 0.80 | 0.50 | 0.50 |
Liver | LIRI-JP | 32 | 0.88 | 0.50 | 0.75 |
Breast | BRCA-US | 189 | 0.75 | 0.60 | 0.50 |
Lung | LUSC-US | 39 | 0.91 | 0.50 | 0.50 |
Esophagous | ESAD-UK | 61 | 0.90 | 0.50 | 0.50 |
Colorectal | COAD-US | 51 | 0.83 | 0.50 | 0.50 |
Breast | BRCA-FR | 15 | 0.82 | 0.50 | 0.56 |
Pancreas | PACA-AU | 73 | 0.72 | 0.60 | 0.50 |
Pancreas | PACA-CA | 54 | 0.87 | 0.50 | 0.89 |
Head & Neck | THCA-US | 76 | 0.85 | 0.85 | 0.50 |
Breast | BRCA-EU | 114 | 0.79 | 0.56 | 0.50 |